NCT07505641

Brief Summary

The ProlEx-Context study aims to investigate how a slow-paced breathing technique with prolonged exhalation affects decision-making in the context of acute social stress.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
9mo left

Started Apr 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
Apr 2026Apr 2027

First Submitted

Initial submission to the registry

March 13, 2026

Completed
19 days until next milestone

First Posted

Study publicly available on registry

April 1, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

April 1, 2026

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

March 13, 2026

Last Update Submit

March 26, 2026

Conditions

Outcome Measures

Primary Outcomes (12)

  • Risk propensity

    The dependent variable will be trial-wise gamble acceptance (accept vs. reject of a 50% gamble), which will be mainly analyzed using a binomial generalized linear mixed-effects model (GLMM) to compare the Prolonged Exhalation and Eupnea conditions under acute stress.

    On day 1.

  • Task-related BOLD Signals

    Task-related changes in blood-oxygen-level-dependent (BOLD) signals measured using functional magnetic resonance imaging (fMRI).

    On day 1.

  • Structural T1-weighted MRI

    High-resolution T1-weighted structural images measured using magnetic resonance imaging (MRI).

    On day 1.

  • Relative amplitude of the respiratory signal

    Task-based and resting-state relative respiratory amplitude, measured via a respiratory belt and nasal airflow sensor.

    On day 1.

  • Respiration rate

    Task-based and resting-state relative respiratory amplitude, measured via a respiratory belt and nasal airflow sensor.

    On day 1.

  • Heart rate

    Task-based and resting-state heart rate, measured with ECG

    On day 1.

  • Heart-rate variability

    Task-based and resting-state heart-rate variability, measured with a three-point electrocardiogram (ECG)

    On day 1.

  • Gastric myoelectrical activity

    Resting-state and task-based gastric myoelectrical activity, measured using cutaneous electrogastrography (EGG).

    On day 1.

  • Tonic skin conductance

    Tonic task-based and resting-state electrodermal activity, measured with EDA electrodes

    On day 1.

  • Event-related skin conductance responses

    Phasic electrodermal activity, measured via electrodermal activity (EDA) electrodes

    On day 1.

  • Salivary Cortisol Levels

    Concentration of cortisol in saliva (measured in nmol/L). This indexes the HPA-axis response to the Trier Social Stress Test (TSST). We will compare the cortisol trajectory

    On day 1.

  • Pupil dilation

    Task-based and resting-state pupil dilation, measured via eye-tracking

    On day 1.

Secondary Outcomes (22)

  • Response Times

    On day 1.

  • Self-reported levels of stress

    On day 1.

  • Self-reported levels of tension

    On day 1.

  • Self-reported levels of heart feeling

    On day 1.

  • Self-reported levels of stomach feeling

    On day 1.

  • +17 more secondary outcomes

Study Arms (2)

Prolonged Exhalation Breathing

EXPERIMENTAL

Participants are required to perform a specific voluntarily controlled breathing pattern directed by visual cues. The core characteristic is a systematic lengthening of the expiratory phase relative to the inspiratory phase. Specifically, participants are instructed to inhale for 2 seconds and prolong their exhalation to 8 seconds

Behavioral: Instructed Prolonged Exhalation

Eupnea Breathing (Normal)

EXPERIMENTAL

Eupnea (Normal breathing) condition: In this control condition, participants maintain their spontaneous respiratory rhythm. The pacing for eupnea is individualized for each participant, based on their natural breathing frequency sampled during representative non-interventional intervals of the session (e.g., baseline or post-stress recovery periods). This ensures the control condition reflects the participant's characteristic physiological state within the experimental context.

Behavioral: Instructed Individualized Eupnea

Interventions

Participants are required to perform a specific instructed breathing pattern directed by visual cues. The core characteristic is a systematic lengthening of the expiratory phase relative to the inspiratory phase. Specifically, participants are instructed to inhale for 2 seconds and prolong their exhalation to 8 seconds.

Prolonged Exhalation Breathing

Instructed Individualized Eupnea: In this control condition, participants are instructed to match their breath to a visual cue that is calibrated to their own characteristic natural respiratory frequency. This frequency is sampled during representative non-interventional phases of the session to capture the participant's individual baseline eupnea pace within the experimental context.

Eupnea Breathing (Normal)

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • to 40-year-old men and women
  • Consent to participate
  • Fluent in German
  • Right-handed
  • Physically and mentally healthy without regular medication
  • Body-mass index of 18-25 kg/m2
  • Alcohol consumption of less than 15 glasses a week (equivalent to one glass of wine/beer, a glass of higher-percentage alcohol counts as two glasses of beer)
  • No illegal drug consumption in the week previous to the experiment
  • No smoking
  • No competitive athletes
  • Normal day-night rhythm (no shift work)
  • Normal vision without required vision correction (i.e., glasses, contact lenses; ability to clearly read texts at a distance of up to 50 cm without vision aids)

You may not qualify if:

  • Former or current illnesses of:
  • Brain or mind (including anxiety disorders, depression, eating disorders, personality disorders, alcohol, drugs or drug dependence, neurological disorders other than occasional headache, psychiatric or neurological abnormalities)
  • Heart or blood circulation
  • Lung Diseases
  • Other serious past or present medical conditions (for example, metabolic syndrome, diabetes)
  • Current medication and medication over a period of two weeks prior to the examination
  • Other serious health problems or present strong mental or physical stress
  • Current infection or excessive stress
  • Missing consent to receive information about incidental findings from the MRI
  • Tendency to claustrophobia, dizziness, or panic attacks
  • Wearing a non-removable pacemaker, defibrillator, hearing aid, drug pump, neurostimulator or implant with solenoid valve (e.g., artificial bowel outlet)
  • Metal parts or implants inside the body, for example, due to surgery or injury with a metallic foreign object (e.g., hip replacements, artificial joints, heart valves, vessel occlusions or dilatations, surgical clips, bone screws or plates, coil, shunts, catheters, electrodes, coils, radiation sources, shrapnel, projectiles, stents)
  • Having non-removable metal parts or metal-containing devices on or in the body
  • Having ferromagnetic metal parts or implants inside the body (e.g., hip replacements, artificial joints, heart valves, vessel occlusions or dilatations, surgical clips, bone screws or plates, coils, shunts, catheters, electrodes, coils, radiation sources, shrapnel, projectiles, stents)
  • Wearing magnetically fixed implants (e.g. amalgam fillings, glass eye)
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (23)

  • Freitag, C. M., Retz-Junginger, P., Retz, W., Seitz, C., Palmason, H., Meyer, J., ... & von Gontard, A. (2007). Evaluation der deutschen version des Autismus-Spektrum-Quotienten (AQ)-die Kurzversion AQ-k. Zeitschrift für klinische Psychologie und Psychotherapie, 36(4), 280-289.

    BACKGROUND
  • Döring, N., & Bortz, J. (1993). Psychometrische Einsamkeitsforschung: Deutsche Neukonstruktion der UCLA Loneliness Scale. Zeitschrift für Klinische Psychologie, 22(3), 224-233.

    BACKGROUND
  • Lang, G. & Bachinger, A. Validation of the German Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) in a community-based sample of adults in Austria: a bi-factor modelling approach. J Public Health 25, 135-146 (2017).

    BACKGROUND
  • Grimm, J. State-trait-anxiety inventory nach Spielberger. Deutsche Lang- und Kurzversion. Methodenforum der Universität Wien: MF-Working Paper (2009).

    BACKGROUND
  • Schwarzer, R., Bäßler, J., Kwiatek, P., Schröder, K., & Zhang, J. X. (1997). The assessment of optimistic self-beliefs: comparison of the German, Spanish, and Chinese versions of the general self-efficacy scale. Applied Psychology, 46(1), 69-88.

    BACKGROUND
  • Fliege, H., Rose, M., Arck, P., Levenstein, S. & Klapp, B. F. (2001). Validierung des "Perceived Stress Questionnaire" (PSQ) an einer deutschen Stichprobe. Diagnostica, 47, 142-152.

    BACKGROUND
  • Janke, S., & Glöckner-Rist, A. (2014). "Deutsche Version der Positive and Negative Affect Schedule (PANAS)" in Zusammenstellung sozialwissenschaftlicher Items und Skalen, GESIS (Mannheim, Germany).

    BACKGROUND
  • Strobel, A., Beauducel, A., Debener, S., & Brocke, B. Eine deutschsprachige Version des BIS/BAS-Fragebogens von Carver und White. [A German version of Carver and White's BIS/BAS scales.]. Zeitschrift für Differentielle und Diagnostische Psychologie 22, 216-227 (2001).

    BACKGROUND
  • Meule, A., Vögele, C. & Kübler, A. Psychometrische Evaluation der deutschen Barratt Impulsiveness Scale - Kurzversion (BIS-15). Diagnostica 57, 126-133 (2011).

    BACKGROUND
  • Rammstedt, B., Kemper, C.J., Klein, M.C., Beierlein, C., & Kovaleva, A. (2013). Eine kurze Skala zur Mes-sung der fünf Dimensionen der Persönlichkeit. Methoden, Daten, Analysen, 7(2), S. 233-249.

    BACKGROUND
  • Hautzinger, M., Bailer, M., Worall, H. and Keller, F. (1994). Das Beck Depressionsinventar (BDI) [The Beck Depression Inventory (BDI)]. Bern: Huber.

    BACKGROUND
  • Backhaus J, Junghanns K, Broocks A, Riemann D, Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. J Psychosom Res. 2002 Sep;53(3):737-40. doi: 10.1016/s0022-3999(02)00330-6.

    PMID: 12217446BACKGROUND
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

    PMID: 2748771BACKGROUND
  • Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB.

    PMID: 12900694BACKGROUND
  • Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ, Schneier FR, Liebowitz MR. Psychometric properties of the Liebowitz Social Anxiety Scale. Psychol Med. 1999 Jan;29(1):199-212. doi: 10.1017/s0033291798007879.

    PMID: 10077308BACKGROUND
  • Chmitorz A, Wenzel M, Stieglitz RD, Kunzler A, Bagusat C, Helmreich I, Gerlicher A, Kampa M, Kubiak T, Kalisch R, Lieb K, Tuscher O. Population-based validation of a German version of the Brief Resilience Scale. PLoS One. 2018 Feb 13;13(2):e0192761. doi: 10.1371/journal.pone.0192761. eCollection 2018.

    PMID: 29438435BACKGROUND
  • Mehling WE, Acree M, Stewart A, Silas J, Jones A. The Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2). PLoS One. 2018 Dec 4;13(12):e0208034. doi: 10.1371/journal.pone.0208034. eCollection 2018.

    PMID: 30513087BACKGROUND
  • Sproesser G, Strohbach S, Schupp H, Renner B. Candy or apple? How self-control resources and motives impact dietary healthiness in women. Appetite. 2011 Jun;56(3):784-7. doi: 10.1016/j.appet.2011.01.028. Epub 2011 Feb 4.

    PMID: 21296115BACKGROUND
  • Tom SM, Fox CR, Trepel C, Poldrack RA. The neural basis of loss aversion in decision-making under risk. Science. 2007 Jan 26;315(5811):515-8. doi: 10.1126/science.1134239.

    PMID: 17255512BACKGROUND
  • Porcelli AJ, Delgado MR. Stress and Decision Making: Effects on Valuation, Learning, and Risk-taking. Curr Opin Behav Sci. 2017 Apr;14:33-39. doi: 10.1016/j.cobeha.2016.11.015.

    PMID: 28044144BACKGROUND
  • De Couck M, Caers R, Musch L, Fliegauf J, Giangreco A, Gidron Y. How breathing can help you make better decisions: Two studies on the effects of breathing patterns on heart rate variability and decision-making in business cases. Int J Psychophysiol. 2019 May;139:1-9. doi: 10.1016/j.ijpsycho.2019.02.011. Epub 2019 Mar 1.

    PMID: 30826382BACKGROUND
  • Bae D, Matthews JJL, Chen JJ, Mah L. Increased exhalation to inhalation ratio during breathing enhances high-frequency heart rate variability in healthy adults. Psychophysiology. 2021 Nov;58(11):e13905. doi: 10.1111/psyp.13905. Epub 2021 Jul 20.

    PMID: 34289128BACKGROUND
  • Allen AP, Kennedy PJ, Dockray S, Cryan JF, Dinan TG, Clarke G. The Trier Social Stress Test: Principles and practice. Neurobiol Stress. 2016 Nov 12;6:113-126. doi: 10.1016/j.ynstr.2016.11.001. eCollection 2017 Feb.

    PMID: 28229114BACKGROUND

Study Officials

  • Soyoung Q Park, Prof. Dr.

    German Institute of Human Nutrition Potsdam-Rehbruecke

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Soyoung Q Park, Prof. Dr.

CONTACT

Wenhao Huang

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants are not informed in advance about the acute social stress induction, but are fully debriefed after completion of the study.
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

March 13, 2026

First Posted

April 1, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

April 1, 2026

Record last verified: 2025-12